Skip to Main Content

Author Details

Jacqueline Fontugne
Institut Curie, CNRS, PSL Research University
2013
27
13
PMIDPaper TitleJournal TitlePublished Year
36273937FGFR3 Mutational Activation Can Induce Luminal-like Papillary Bladder Tumor Formation and Favors a Male Sex Bias.Eur Urol2023
37558130Transcriptomic Profiling of Upper Tract Urothelial Carcinoma: Bladder Cancer Consensus Classification Relevance, Molecular Heterogeneity, and Differential Immune Signatures.Mod Pathol2023
36980628Refining the Characterization and Outcome of Pathological Complete Responders after Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer: Lessons from the Randomized Phase III VESPER (GETUG-AFU V05) Trial.Cancers (Basel)2023
36695554Progression-associated molecular changes in basal/squamous and sarcomatoid bladder carcinogenesis.J Pathol2023
35050902Collision tumors revealed by prospectively assessing subtype-defining molecular alterations in 904 individual prostate cancer foci.JCI Insight2022
36033544Integrated molecular and pharmacological characterization of patient-derived xenografts from bladder and ureteral cancers identifies new potential therapies.Front Oncol2022
33743486Tertiary lymphoid structures marker CXCL13 is associated with better survival for patients with advanced-stage bladder cancer treated with immunotherapy.Eur J Cancer2021
32332823Integrative multiplatform molecular profiling of benign prostatic hyperplasia identifies distinct subtypes.Nat Commun2020
32037144Reply To Kenneth B. Yatai, Mark J. Dunning, Dennis Wang. Consensus Genomic Subtypes of Muscle-invasive Bladder Cancer: A Step in the Right Direction but Still a Long Way To Go. Eur Urol 2020;77:434-5.Eur Urol2020
32988402Identification of new driver and passenger mutations within APOBEC-induced hotspot mutations in bladder cancer.Genome Med2020
31524642Multicenter Validation of Histopathologic Tumor Regression Grade After Neoadjuvant Chemotherapy in Muscle-invasive Bladder Carcinoma.Am J Surg Pathol2019
28753865Prognostic Biomarkers Used for Localised Prostate Cancer Management: A Systematic Review.Eur Urol Focus2018
29925856HPV RNA CISH score identifies two prognostic groups in a p16 positive oropharyngeal squamous cell carcinoma population.Mod Pathol2018
27633611Cold-associated perniosis of the thighs histopathologically mimicking lupus. Six observations.J Eur Acad Dermatol Venereol2017
28464947Erratum to: Unraveling the clonal hierarchy of somatic genomic aberrations.Genome Biol2017
28445951PD-L1 expression in perihilar and intrahepatic cholangiocarcinoma.Oncotarget2017
29333526Next-Generation Rapid Autopsies Enable Tumor Evolution Tracking and Generation of Preclinical Models.JCO Precis Oncol2017
28762374Molecular alterations in prostate cancer and association with MRI features.Prostate Cancer Prostatic Dis2017
26743468Clonal evaluation of prostate cancer foci in biopsies with discontinuous tumor involvement by dual ERG/SPINK1 immunohistochemistry.Mod Pathol2016
26181256Whole-Exome Sequencing of Metastatic Cancer and Biomarkers of Treatment Response.JAMA Oncol2015
24515272Recurrent prostate cancer genomic alterations predict response to brachytherapy treatment.Cancer Epidemiol Biomarkers Prev2014
25420520ERG induces taxane resistance in castration-resistant prostate cancer.Nat Commun2014
25415230The oestrogen receptor alpha-regulated lncRNA NEAT1 is a critical modulator of prostate cancer.Nat Commun2014
25160065Unraveling the clonal hierarchy of somatic genomic aberrations.Genome Biol2014
22914609Incidental finding of small "lipoma-like" tumor during hepatic lobectomy for metastatic adenocarcinoma.Appl Immunohistochem Mol Morphol2013
22953790Extensive pneumatosis coli misdiagnosed and mismanaged as polyposis.Scand J Gastroenterol2013
23388128Inflammatory bowel disease-associated colorectal cancers and microsatellite instability: an original relationship.Am J Surg Pathol2013
  • 1 - 27 of 27

Recommended Authors

Caryl and Israel Englander Institute for Precision Medicine
Career Start Year 2017
Number of shared co-authors 39
The Institute for Cancer Research
Career Start Year 2015
Number of shared co-authors 5
University of California San Francisco
Career Start Year 2014
Number of shared co-authors 10
University of Michigan Medical School ann arbor
Career Start Year 2012
Number of shared co-authors 12
University of Toronto
Career Start Year 2012
Number of shared co-authors 1
Royal Marsden NHS Foundation Trust
Career Start Year 2011
Number of shared co-authors 0
Dana-Farber Cancer Institute
Career Start Year 2009
Number of shared co-authors 28
University of Basel
Career Start Year 2008
Number of shared co-authors 11
McGill University Health Centre, McGill University
Career Start Year 2007
Number of shared co-authors 7
University of Toronto
Career Start Year 2006
Number of shared co-authors 1
Johns Hopkins University School of Medicine
Career Start Year 2006
Number of shared co-authors 23
Centre hospitalier de l'Universite de Montreal
Career Start Year 2006
Number of shared co-authors 0
Fred Hutchinson Cancer Center
Career Start Year 2005
Number of shared co-authors 15
Institute of Pathology, University Hospital Heidelberg
Career Start Year 2005
Number of shared co-authors 1
Massachusetts General Hospital/Harvard Medical School
Career Start Year 2004
Number of shared co-authors 1
University of British Columbia
Career Start Year 2004
Number of shared co-authors 15
Cambridge University Hospitals National Health Service Foundation Trust
Career Start Year 2003
Number of shared co-authors 4
Memorial Sloan Kettering Cancer Center
Career Start Year 2003
Number of shared co-authors 29
University of Calgary Cumming School of Medicine, Rockyview General Hospital
Career Start Year 2002
Number of shared co-authors 20
Michigan Center for Translational Pathology, University of Michigan ann arbor
Career Start Year 2002
Number of shared co-authors 25
Institute of Pathology, Ludwig-Maximilians-Universitat Munchen
Career Start Year 2002
Number of shared co-authors 0
Centre Hospitalier de l'Universite de Montreal
Career Start Year 2001
Number of shared co-authors 4
Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center
Career Start Year 2000
Number of shared co-authors 27
Centre de Recherche du CHU de Quebec-Universite Laval (axe Oncologie)
Career Start Year 1999
Number of shared co-authors 3
Michigan Center for Translational Pathology.
Career Start Year 1999
Number of shared co-authors 24
Princess Margaret Cancer Center, University Health Network.
Career Start Year 1996
Number of shared co-authors 5
Career Start Year 1995
Number of shared co-authors 0
Georgetown University
Career Start Year 1993
Number of shared co-authors 0
Queen's University
Career Start Year 1982
Number of shared co-authors 5
Foundation Medicine
Career Start Year 1974
Number of shared co-authors 10

Collaborators

University of Bern
Co-authored papers 11
Caryl and Israel Englander Institute for Precision Medicine
Co-authored papers 10
Institute for Computational Biomedicine
Co-authored papers 7
University of Trento
Co-authored papers 6
Weill Cornell Medical College
Co-authored papers 6
Dana-Farber Cancer Institute
Co-authored papers 6
CNRS, Institut Curie, PSL Research University, Universite Paris Cite
Co-authored papers 5
Meyer Cancer Center
Co-authored papers 5
Caryl and Israel Englander Institute for Precision Medicine
Co-authored papers 5
New York University Langone Health
Co-authored papers 5
University of Trento
Co-authored papers 4
University of Trento
Co-authored papers 4
Meyer Cancer Center, Weill Cornell Medicine-NewYork Presbyterian Hospital
Co-authored papers 3
Sandra and Edward Meyer Cancer Center
Co-authored papers 3
INSERM, Universite Clermont Auvergne
Co-authored papers 3
Sandra and Edward Meyer Cancer Center
Co-authored papers 3
Icahn School of Medicine at Mount Sinai
Co-authored papers 2
Institute for Pathology, University Hospital Schleswig-Holstein
Co-authored papers 2
University Hospital Zurich
Co-authored papers 2
Vattikuti Urology Institute
Co-authored papers 2
Co-authored papers 2
Columbia University, United States Bureau of Educational and Cultural Affairs Fulbright Program, University of Piraeus, Weill Cornell Medical College, Weill Cornell Medicine
Co-authored papers 2
Weill Cornell Medicine and New York Presbyterian Hospital
Co-authored papers 2
Michigan Center for Translational Pathology, University of Michigan ann arbor
Co-authored papers 2
Sandra and Edward Meyer Cancer Center
Co-authored papers 2
Broad Institute of Harvard and MIT
Co-authored papers 2
Meyer Cancer Center
Co-authored papers 2
Caryl and Israel Englander Institute for Precision Medicine
Co-authored papers 2
University of California
Co-authored papers 2
Variant Bio Inc.
Co-authored papers 2